Clinical Trial Update: Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing triple therapy (PDT with verteporfin and intravitreal ranibizumab) to ranibizumab monotherapy for age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Bay Area Retina Associates | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED